Medsafe blocks sales of Covid-19 'treatment' Artemisia annua

Medsafe has won praise for moving quickly to stop sales of a herbal remedy linked to Covid-19.

Artemisia Spp. Derivatives for COVID-19 Treatment: Anecdotal Use, Political Hype, Treatment Potential, Challenges, and Road Map to Randomized Clinical Trials in: The American Journal of Tropical Medicine and Hygiene Volume 103 Issue 3 (2020)

Artemisia, a solution at the heart of One Health - La Maison de l' Artemisia - This plant can save millions of lives

COVID-19 Lockdown Exit Analysis

A Pilot Study of Ocrelizumab Infusion Reaction Rates Among Multiple Sclerosis Patients Treated in a Hospital and 2 Outpatient Sites of Care - National Home Infusion Association

Columbia resident overcomes challenges of Friedreich's ataxia with newly-approved treatment, Mid-Missouri News

Covid 19 coronavirus: Medsafe blocks sales of 'treatment' Artemisia annua - NZ Herald

Artemisia annua, an inexpensive alternative to Covid-19 - very promising leads! - La Maison de l'Artemisia - This plant can save millions of lives

Therapeutic advances in COVID-19

Artemisia, a solution at the heart of One Health - La Maison de l' Artemisia - This plant can save millions of lives

Avalo® Series AC Bin Cassette Medication Cart - Capsa Healthcare

An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment - ScienceDirect

Arvin America's Arthrocen 300: A Promising New Osteoarthritis ASU Supplement for Joint Pain

Cost-Utility and Cost-Effectiveness Analysis of disease-modifying drugs of Relapsing-Remitting Multiple Sclerosis: A Systematic Review

Artemisia Annua Could Be Promising Treatment for COVID-19

The Global Science and Politics of Covid-19 / SARS-CoV-2